A new vaccine that does a better job of preventing shingles was developed by researchers at the University of Colorado Anschutz Medical Campus. The Food and Drug Administration approved the new vaccine -- called Shingrix -- last week and the Centers for Disease Control’s Advisory Committee on Immunization Practices recommended it for patients 50 and older this week. The committee also recommended using Shingrix instead of the currently-available vaccine Zostavax.
13001 East 17th Place
Aurora, CO 80045